サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1754299

神経血管デバイスの市場規模、シェア、動向、予測：製品、用途、エンドユーザー、地域別、2025～2033年

Neurovascular Devices Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 143 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.06円
神経血管デバイスの市場規模、シェア、動向、予測：製品、用途、エンドユーザー、地域別、2025～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経血管デバイスの世界市場規模は2024年に30億米ドルとなりました。今後、IMARC Groupは、同市場が2033年までに47億米ドルに達し、2025～2033年にかけて4.9％のCAGRを示すと予測しています。現在市場を独占しているのは北米で、2024年の市場シェアは27.8%です。北米地域の成長の原動力は、先進的ヘルスケアインフラ、革新的な神経血管デバイスの普及、神経血管障害の症例増加、研究イニシアティブへの強力な支援です。

現在、大衆の間で脳卒中、動脈瘤、動静脈奇形などの疾患の発生率が上昇していることが、市場成長を促す主要因の1つとなっています。これらの疾患には正確な治療が必要であり、現代の神経血管器具はそれに取り組むよう調整されており、患者の生存率と全体的な生活の質を高めています。さらに、神経血管の問題を抱えやすい高齢者の増加が、高齢者特有のヘルスケア要件に合わせた強化された治療ソリューションの需要を促進しています。さらに、フローダイバータ、血栓除去装置、塞栓コイルのような低侵襲技術の進歩は、手技結果を向上させています。これらのデバイスは、リスクを低減し、回復期間を短縮し、カスタマイズ型ソリューションを提供することで、世界のヘルスケア環境での広範な使用を促進しています。さらに、多くの国で償還制度が強化されたことで、患者は高価な神経血管治療を受けられるようになり、神経血管デバイスはより手頃な価格で利用しやすくなっています。

米国は、治療の精度と安全性を高めるために特別に設計された革新的な神経血管デバイスの導入に支えられた主要市場です。視認性と配置精度を高めるコイルアシストステントなどの最先端技術の存在は、複雑な神経血管の問題を効果的に治療することにますます重点が置かれていることを示しています。こうした進歩は、臨床要件に合わせてカスタマイズ型革新的ソリューションの提供に対するトップメーカーの献身を強調しています。例えば、2024年、MicroVentionは、広頚部頭蓋内動脈瘤の治療を目的としたLVIS EVO Intraluminal Support Deviceの米国での商業的リリースを宣言しました。これは米国で最初の完全に可視化されたコイルアシスト頭蓋内ステントであり、可視化と正確な位置決めが改善されています。この発売は、神経血管治療技術の進歩に対するマイクロベンションのコミットメントを強調するものです。さらに、脳卒中の予防、迅速な診断、治療の選択に関する啓蒙プログラムの増加は、迅速な医療介入につながっています。専門家開発プログラムもヘルスケア従事者の能力を高め、先進的技術の使用を促しています。

神経血管デバイス市場動向

技術革新がイノベーションを促進

世界の神経血管デバイスのセグメントでは、技術革新の進行が重要な要素となっています。医療機器の進歩は神経血管の処置を一変させ、さまざまな神経血管の問題に対する新たな治療選択肢を提供しています。Institute for Health Metrics and Evaluationの報告によると、2021年に病気、障害、早期死亡によって失われる健康寿命は、神経疾患で4億4,300万年にのぼるといいます。3Dプリンティング、先進的画像技術、低侵襲アプローチなどの最先端技術は、患者ケアに革命をもたらしています。これらの開発により、より正確な診断と治療が可能になり、患者の転帰が向上し、リスクが軽減されます。さらに、神経血管インターベンションにおけるロボット工学と人工知能（AI）の統合は、手技を大幅に改善し、個別化された治療を提供しています。継続的な研究開発（R&D）により、技術進歩の絶え間ない追求が神経血管デバイス市場を牽引しています。

神経血管障害の有病率の上昇

世界の神経血管デバイス市場の上昇軌道は、神経血管障害の有病率の上昇と本質的に関連しています。報告によると、2021年には世界中で30億人以上が神経障害の影響を受けています。世界規模での健康課題は、脳卒中、動脈瘤、動静脈奇形などの疾患によって著しくもたらされます。高齢者は、ライフスタイルの変化やリスク要素とともに、これらの疾患の発生増加につながっています。このような症例の増加には、正確な診断、治療、治療後のモニタリングのための効率的で最新の神経血管器具の開発が必要です。患者の不快感を軽減し、回復期間を短縮するため、低侵襲手技の需要が顕著に増加しています。その結果、市場は独創的な製品とソリューションでこの需要増に対応し、患者の治療結果と全体的な生活の質を高める重要な要因としての役割を強化しています。

高齢者と低侵襲治療へのアクセシビリティ

高齢者は、世界の神経血管デバイス市場拡大の重要な促進要因となっています。国勢調査局によると、2020年には高齢者は5,580万人に達し、米国人口全体の16.8％を占めます。高齢者が神経血管疾患に罹患しやすくなっていることから、包括的かつ低侵襲な治療オプションに対する需要が高まっています。高齢者は通常、身体的ストレスや回復時間を軽減する低侵襲の手技を好みます。その結果、生産者はこの患者グループに合わせた機器の開発に注力し、安全性と効率性を確保しています。低侵襲治療が可能になることで、患者のコンプライアンスが向上し、ヘルスケア産業では効果的で経済的な選択肢が重視され続けています。高齢化社会のニーズと市場で入手可能な製品との関連は、進化するヘルスケア需要に対応するための神経血管デバイスセグメントの重要な役割を浮き彫りにしています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の神経血管デバイス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 脳塞栓術と動脈瘤コイル塞栓術
    • 主要セグメント
      • 塞栓コイル
      • フローダイバーター
      • 液体塞栓剤
  • 脳血管形成術とステント留置システム
    • 主要セグメント
      • 頸動脈ステント
      • 塞栓保護デバイス
  • 神経血栓除去デバイス
    • 主要セグメント
      • 血栓除去デバイス
      • 吸引装置
      • 血管スネア
  • サポートデバイス
    • 主要セグメント
      • マイクロカテーテル
      • マイクロガイドワイヤ

第7章 市場内訳：用途別

  • 虚血性脳卒中
  • 動脈瘤
  • 動静脈奇形と瘻孔（AVM）
  • 狭窄
  • その他

第8章 市場内訳：エンドユーザー別

  • 病院
  • 外来手術センター
  • クリニック
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Acandis GmbH
    • Asahi Intecc Co. Ltd.
    • Imperative Care Inc.
    • Integer Holdings Corporation
    • Johnson & Johnson
    • Medtronic plc
    • MicroPort Scientific Corporation
    • Penumbra Inc.
    • Perflow Medical Ltd.
    • Rapid Medical
    • Stryker Corporation
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Neurovascular Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Neurovascular Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Neurovascular Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Neurovascular Devices Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Neurovascular Devices Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Neurovascular Devices Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Neurovascular Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Neurovascular Devices (Cerebral Embolization and Aneurysm Coiling Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Neurovascular Devices (Cerebral Embolization and Aneurysm Coiling Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Neurovascular Devices (Cerebral Angioplasty and Stenting Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Neurovascular Devices (Cerebral Angioplasty and Stenting Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Neurovascular Devices (Neurothrombectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Neurovascular Devices (Neurothrombectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Neurovascular Devices (Support Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Neurovascular Devices (Support Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Neurovascular Devices (Ischemic Stroke) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Neurovascular Devices (Ischemic Stroke) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Neurovascular Devices (Aneurysm) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Neurovascular Devices (Aneurysm) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Neurovascular Devices (Arteriovenous Malformation and Fistulas (AVM)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Neurovascular Devices (Arteriovenous Malformation and Fistulas (AVM)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Neurovascular Devices (Stenosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Neurovascular Devices (Stenosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Neurovascular Devices (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Neurovascular Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Neurovascular Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Neurovascular Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Neurovascular Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Neurovascular Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Neurovascular Devices (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Neurovascular Devices (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Neurovascular Devices (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Neurovascular Devices (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Neurovascular Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Neurovascular Devices Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Neurovascular Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Neurovascular Devices Industry: SWOT Analysis
  • Figure 84: Global: Neurovascular Devices Industry: Value Chain Analysis
  • Figure 85: Global: Neurovascular Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Neurovascular Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Neurovascular Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Neurovascular Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Neurovascular Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Neurovascular Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Neurovascular Devices Market: Competitive Structure
  • Table 7: Global: Neurovascular Devices Market: Key Players
目次
Product Code: SR112025A6128

The global neurovascular devices market size was valued at USD 3.0 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.7 Billion by 2033, exhibiting a CAGR of 4.9% from 2025-2033. North America currently dominates the market, holding a market share of 27.8% in 2024. The growth of the North American region is driven by advanced healthcare infrastructure, widespread adoption of innovative neurovascular devices, increasing cases of neurovascular disorders, and strong support for research initiatives.

At present, the rising incidence of conditions, such as strokes, aneurysms, and arteriovenous malformations, among the masses represent one of the major factors impelling the market growth. These conditions necessitate exact treatment, which contemporary neurovascular instruments are tailored to tackle, enhancing patient survival rates and overall quality of life. Moreover, the increasing elderly population, which is more prone to neurovascular issues, is driving the demand for enhanced treatment solutions tailored to their unique healthcare requirements. Additionally, advancements in less invasive technologies, like flow diverters, thrombectomy devices, and embolization coils, are enhancing procedural results. These devices lower risks, shorten recovery durations, and provide customized solutions, promoting extensive use in healthcare settings globally. Furthermore, enhanced reimbursement systems in numerous countries allow patients to obtain expensive neurovascular therapies, rendering neurovascular devices more affordable and accessible.

The United States represents a major market, supported by the introduction of innovative neurovascular devices specifically designed to enhance treatment precision and safety. The presence of cutting-edge technologies, such as coil-assist stents, which enhance visibility and placement precision, indicates an increasing emphasis on effectively treating intricate neurovascular issues. These advancements emphasize the dedication of top manufacturers to providing innovative solutions customized for clinical requirements. For instance, in 2024, MicroVention declared the commercial release of the LVIS EVO Intraluminal Support Device in the United States, intended for the treatment of wide-neck intracranial aneurysms. It is the initial entirely visible coil-assist intracranial stent in the US, providing improved visualization and accurate positioning. This launch underscores MicroVention's commitment to advancing neurovascular treatment technologies. Furthermore, the growing number of awareness programs about stroke prevention, rapid diagnosis, and treatment choices is leading to quicker medical intervention. Professional development programs are also enhancing the abilities of healthcare workers, encouraging the use of sophisticated technology.

Neurovascular Devices Market Trends:

Technological advancements driving innovation

In the field of global neurovascular devices, a vital factor is the ongoing rise in technological innovations. Advancements in medical devices have transformed neurovascular procedures, offering novel treatment options for a range of neurovascular problems. The Institute for Health Metrics and Evaluation reports that neurological disorders accounted for 443 million years of healthy life lost from illness, disability, and early death in 2021. Cutting-edge technologies such as 3D printing, advanced imaging techniques, and minimally invasive approaches are revolutionizing patient care. These developments enable more precise diagnosis and treatment, enhancing patient outcomes and reducing risks. Moreover, the integration of robotics and artificial intelligence (AI) in neurovascular interventions is greatly improving procedures and offering personalized therapies. With ongoing research and development (R&D), the relentless pursuit of technological progress drives the neurovascular devices market.

Rising prevalence of neurovascular disorders

The upward trajectory of the global neurovascular devices market is intrinsically linked to the rising prevalence of neurovascular disorders. Reports indicate that in 2021, over 3 billion individuals around the globe were affected by a neurological disorder. Health challenges on a global scale are significantly posed by conditions like strokes, aneurysms, and arteriovenous malformations. The elderly population, along with shifting lifestyles and risk elements, has led to an increased occurrence of these conditions. This increase in cases requires the creation of efficient and modern neurovascular instruments for precise diagnosis, therapy, and monitoring after treatment. The demand for minimally invasive procedures has notably increased because of their lowered patient discomfort and faster recovery periods. As a result, the market addresses this increasing demand with creative products and solutions, reinforcing its role as a crucial factor in enhancing patient results and overall quality of life.

Geriatric population and accessibility to minimally invasive treatments

The geriatric demographic stands as a significant driver in the expansion of the global neurovascular devices market. According to the Census Bureau, in 2020, the senior population reached 55.8 million, representing 16.8% of the overall US populace. With the growing susceptibility of the elderly population to neurovascular diseases, the demand for comprehensive and minimally invasive treatment options increases. Older individuals usually prefer minimally invasive procedures that lessen physical stress and recovery time. As a result, producers focus on developing devices tailored for this patient group, ensuring their safety and efficiency. The availability of minimally invasive treatments improves patient compliance and addresses the ongoing emphasis in the healthcare industry on effective and economical options. The link between the needs of the aging population and the market's available products highlights the crucial role of the neurovascular devices sector in meeting evolving healthcare demands.

Neurovascular Devices Industry Segmentation:

Analysis by Product:

  • Cerebral Embolization and Aneurysm Coiling Devices
    • Embolic Coils
    • Flow Diverters
    • Liquid Embolic Agents
  • Cerebral Angioplasty and Stenting Systems
    • Carotid Artery Stents
    • Embolic Protection Devices
  • Neurothrombectomy Devices
    • Clot Retrieval Devices
    • Suction Devices
    • Vascular Snares
  • Support Devices
    • Micro Catheters
    • Micro Guidewires

Cerebral and aneurysm coiling devices (embolic coils, flow diverters, and liquid embolic agents) lead the market with 37.8% of market share in 2024. Cerebral embolization and aneurysm coiling devices dominate the market due to their demonstrated efficacy in treating critical conditions like aneurysms and arteriovenous malformations. Such devices, like embolic coils, flow diverters, and liquid embolic agents, provide less invasive treatment alternatives that greatly decrease recovery durations and procedural hazards. Their accuracy in detecting aneurysms and averting rupture has rendered them essential in neurovascular procedures. Ongoing technological progress has improved their effectiveness, allowing customized solutions for various patient requirements. These devices are commonly used in modern healthcare centers, bolstered by the increasing recognition of their advantages among healthcare practitioners. Cerebral embolization and aneurysm coiling devices have become essential in this market segment due to their vital role in tackling the rising incidence of neurovascular disorders, fostering innovation and enhancing patient outcomes.

Analysis by Application:

  • Ischemic Stroke
  • Aneurysm
  • Arteriovenous Malformation and Fistulas (AVM)
  • Stenosis
  • Others

Ischemic stroke is a significant segment in the market, driven by the rising global incidence of strokes. These instruments, such as thrombectomy devices and stents, are essential in restoring blood circulation and reducing brain injury during crises. The rise in their adoption is driven by progress in less invasive techniques and a heightened focus on early intervention, leading to better patient results.

Aneurysm is a significant issue, as untreated cerebral aneurysms can lead to death. Devices like embolic coils and flow diverters play a vital role in isolating aneurysms, preventing rupture, and reducing complications. Continuous improvements in device design and a rising application in advanced medical settings are enhancing this segment's importance in successfully addressing complex neurovascular challenges.

Arteriovenous malformation and fistulas (AVM) benefits from specialized neurovascular devices that safely and efficiently manage abnormal blood vessel connections. Liquid embolics and other embolization devices are widely used to reduce bleeding risks and enhance treatment success rates. Increasing awareness about AVM conditions and advancements in imaging technologies further drive the adoption of these devices.

Stenosis is vital segment in the market driven by the increasing demand for treatments for constricted blood vessels in the brain. Stenting systems and balloon angioplasty tools are essential for restoring adequate blood circulation, lowering the likelihood of stroke, and enhancing long-term vascular wellness. The segment is experiencing expansion because of the rising occurrence of atherosclerosis and associated ailments.

Others encompass various neurovascular conditions requiring specialized interventions. This category includes devices designed for rare or complex disorders, such as dural fistulas or Moyamoya disease. The ongoing development of targeted solutions and the expansion of clinical applications highlight the importance of this segment in addressing diverse patient needs.

Analysis by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Hospitals lead the market, holding a 70.9% share in 2024. Hospitals hold the largest market share attributed to their advanced infrastructure and ability to handle complex neurovascular procedures. They offer access to multidisciplinary teams of specialists, ensuring comprehensive care for patients with stroke, aneurysms, and other neurovascular disorders. The availability of state-of-the-art equipment and facilities for diagnosis and minimally invasive treatments enhances the success rate of procedures performed in hospitals. High patient inflow, combined with round-the-clock emergency services, positions hospitals as the primary choice for neurovascular treatments. Their emphasis on clinical training and adoption of innovative technologies ensures the integration of the latest devices and techniques into practice. Hospitals' capability to effectively handle both acute and chronic neurovascular cases makes them crucial in promoting the use of neurovascular devices.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America held the biggest market share at 27.8%. North America leads the market because of its sophisticated healthcare infrastructure and the extensive access to state-of-the-art medical technologies. The area enjoys a significant number of well-equipped medical centers and a vast array of proficient healthcare experts specializing in neurovascular procedures. Continual research and development efforts, backed by strong government and private sector investment, have hastened the launch of innovative devices designed for intricate neurological disorders. The increasing recognition of neurovascular conditions and the significance of prompt treatment further propel the uptake of these devices. Moreover, North America possesses a robust regulatory system that promotes prompt product approvals, guaranteeing the accessibility of safe and efficient treatment alternatives. The presence of key market players in the region enhances accessibility to a wide range of neurovascular devices, fostering continuous advancements. In 2024, Cerenovus, part of Johnson & Johnson MedTech, launched the Cereglide 71 catheter for acute ischemic stroke revascularization in the U.S. Featuring TruCourse technology, it offers improved navigation, trackability, and compatibility for thrombectomy procedures. This innovation enhances Cerenovus' Stroke Solutions portfolio, addressing critical clinical needs in stroke care.

Key Regional Takeaways:

United States Neurovascular Devices Market Analysis

The United States represented 70.10% of the overall market share in North America. The market for neurovascular devices in the United States is presently propelled by innovations in minimally invasive surgical methods, allowing quicker recovery periods and fewer complications for patients receiving care for neurovascular issues. Firms are proactively putting resources into creating advanced devices, like stent retrievers and flow diverters, which are showing enhanced effectiveness in treating ischemic and hemorrhagic strokes. The market is also experiencing a rise in the use of AI-driven imaging technologies and robotic-assisted treatments, which are improving accuracy and clinical results in neurovascular procedures. Increasing awareness initiatives are informing healthcare professionals and patients about the early detection and management of neurovascular conditions, thus broadening the base of patients pursuing these advanced options. Hospitals and surgical facilities are emphasizing the integration of advanced neurovascular device technologies to enhance procedural efficiency and meet the increasing patient demand. Moreover, insurance companies are increasing coverage for cutting-edge procedures, thus making advanced neurovascular treatments more available to a wider audience. According to the U.S. Department of Agriculture (USDA), the United States population hit 334,914,895 in 2023. The FDA is promoting a competitive environment that stimulates innovation by expediting the authorization and approval of novel neurovascular devices. Medical facilities are also improving their training programs for physicians to improve their proficiency with these complex gadgets, which will expand their market reach.

Europe Neurovascular Devices Market Analysis

The market for neurovascular devices in Europe is presently expanding due to a combination of factors. The area is experiencing a rise in the use of sophisticated minimally invasive techniques for addressing neurovascular conditions like aneurysms, ischemic strokes, and arteriovenous malformations, as medical professionals aim to shorten recovery periods and enhance patient results. Governments and private entities are vigorously financing research and clinical studies for cutting-edge devices such as flow diverters and embolization coils, which is hastening product development and market introduction. At the same time, the increasing elderly population in Europe is leading to a higher incidence of neurovascular diseases, encouraging healthcare systems to enhance their neurointerventional services. As reported by Eurostat, in 2019, there were 90.4 million elderly individuals (aged 65 and above) residing in the EU-27. Hospitals and specialized clinics are consistently enhancing their equipment collections to feature advanced imaging and navigation technologies that support neurovascular devices, improving procedural precision. Moreover, European regulatory authorities are simplifying approval procedures for novel neurovascular devices, promoting quicker market entry of innovative solutions. As emphasis on international collaborations increases, manufacturers are establishing strategic alliances with research institutes and hospitals, promoting innovation that meets local requirements. Additionally, the growing accessibility of training programs for neurointerventional specialists is enhancing procedural skills, facilitating the use of neurovascular devices in everyday clinical practice throughout Europe.

Asia Pacific Neurovascular Devices Market Analysis

The neurovascular devices market in the Asia-Pacific region is presently experiencing growth fueled by various localized factors. Improvements in healthcare systems in developing nations such as India and Indonesia are facilitating improved access to neurovascular treatments, bolstered by government efforts to increase the accessibility of sophisticated medical equipment. The area is experiencing a rise in neurovascular disorders like strokes and aneurysms, linked to lifestyle changes, an aging population, and a higher occurrence of hypertension and diabetes. As per the IDF Diabetes Atlas, the number of individuals impacted by diabetes (in thousands) in China in 2021 is 140,869.6. Healthcare providers are progressively embracing minimally invasive techniques because of their reduced risk factors and quicker recovery periods, driving the need for sophisticated neurovascular tools such as embolic coils and flow diverters. Top manufacturers are partnering with local distributors and establishing strategic alliances to broaden their presence, particularly in markets such as China and Japan, where rapid adoption of advanced devices is driven by an increasing emphasis on state-of-the-art medical technologies. At the same time, the growth of medical tourism in nations like Thailand and Malaysia is enhancing access to cost-effective and high-quality neurovascular treatments, drawing in patients from around the world. Regulatory authorities in the area are simplifying approval procedures, enabling quicker market access for advanced neurovascular products, thus fostering innovation and rivalry in the Asia-Pacific market.

Latin America Neurovascular Devices Market Analysis

The neurovascular devices market in Latin America is supported by the growing acceptance of minimally invasive surgical methods and increased awareness among patients and healthcare providers about their benefits, including quicker recovery times and lower complication risks. Hospitals and specialized clinics are upgrading their infrastructure and resources, focusing on equipping facilities with advanced neurovascular equipment to meet the increasing demand for stroke care and other neurovascular disorders. The region is seeing a rise in healthcare investment, especially in countries like Brazil and Mexico, where officials are concentrating on enhancing neurology services through collaborations between public and private sectors. Additionally, companies are actively launching creative products tailored to the specific needs of Latin American communities, addressing issues such as affordability and accessibility. The growing prevalence of lifestyle-associated risk factors, such as hypertension and diabetes, is contributing to a greater number of strokes, consequently increasing reliance on advanced technologies for clot removal and aneurysm management. As per the IDF Diabetes Atlas, the diabetes prevalence in Mexico was approximately 17% in 2021. At the same time, healthcare professionals regularly participate in specialized training sessions provided by device manufacturers to guarantee the effective use of these technologies. Community programs that encourage early detection and treatment offer extra assistance to the market, leading to improved patient results.

Middle East and Africa Neurovascular Devices Market Analysis

The neurovascular device market in the Middle East and Africa is growing due to multiple region-specific factors. To address the growing prevalence of neurovascular diseases including aneurysms and strokes, governments and commercial healthcare organizations are now investing more in healthcare infrastructure, especially in institutions devoted to neurology. Medical tourism is expanding in countries like the UAE and South Africa, supported by advanced neurological treatment facilities that are encouraging the utilization of minimally invasive neurovascular devices. According to the Ministry of Economy, the medical tourism industry in the UAE generated AED 12.1 Billion (USD 3.29 Billion) in 2018. Concurrently, regional healthcare entities are strengthening partnerships with international producers to launch advanced technological devices in the market, addressing the unmet needs in stroke management and interventional neurology. Furthermore, the rising prevalence of hypertension, diabetes, and sedentary habits is elevating the demand for new approaches to tackle associated neurovascular problems. Training sessions and workshops are being conducted more frequently to improve the abilities of healthcare professionals in using advanced equipment, thereby guaranteeing improved patient results. Governments are swiftly accelerating regulatory clearances and endorsing clinical trials in this field, enhancing access to groundbreaking neurovascular products. These elements are jointly establishing a conducive atmosphere for the continuous expansion of the neurovascular devices market in the region.

Competitive Landscape:

Key players in the market are focusing on expanding their product portfolios through innovative solutions and advanced technologies to address complex neurovascular conditions. They are heavily investing in research operations to enhance device efficiency, safety, and minimally invasive capabilities. Strategic collaborations, mergers, and acquisitions are being pursued to strengthen market presence and gain access to emerging regions. These companies are also prioritizing regulatory approvals to ensure global availability and compliance with healthcare standards. Additionally, they are leveraging advanced manufacturing techniques to reduce production costs while maintaining quality. In 2024, Philips and Medtronic Neurovascular announced a joint advocacy initiative designed to enhance global access to essential stroke therapies. The collaboration seeks to raise awareness, improve access to treatments, and implement advanced technologies for effective stroke care management. The two firms joined the World Stroke Organization Advocacy Coalition to advocate for global stroke care policies.

The report provides a comprehensive analysis of the competitive landscape in the neurovascular devices market with detailed profiles of all major companies, including:

  • Acandis GmbH
  • Asahi Intecc Co. Ltd.
  • Imperative Care Inc.
  • Integer Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Penumbra Inc.
  • Perflow Medical Ltd.
  • Rapid Medical
  • Stryker Corporation
  • Terumo Corporation

Key Questions Answered in This Report

  • 1.What are neurovascular devices?
  • 2.How big is the neurovascular devices market?
  • 3.What is the expected growth rate of the global neurovascular devices market during 2025-2033?
  • 4.What are the key factors driving the global neurovascular devices market?
  • 5.What is the leading segment of the global neurovascular devices market based on product?
  • 6.What is the leading segment of the global neurovascular devices market based on end user?
  • 7.What are the key regions in the global neurovascular devices market?
  • 8.Who are the key players/companies in the global neurovascular devices market?q

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Neurovascular Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Cerebral Embolization and Aneurysm Coiling Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Embolic Coils
      • 6.1.2.2 Flow Diverters
      • 6.1.2.3 Liquid Embolic Agents
    • 6.1.3 Market Forecast
  • 6.2 Cerebral Angioplasty and Stenting Systems
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Carotid Artery Stents
      • 6.2.2.2 Embolic Protection Devices
    • 6.2.3 Market Forecast
  • 6.3 Neurothrombectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Clot Retrieval Devices
      • 6.3.2.2 Suction Devices
      • 6.3.2.3 Vascular Snares
    • 6.3.3 Market Forecast
  • 6.4 Support Devices
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Micro Catheters
      • 6.4.2.2 Micro Guidewires
    • 6.4.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Ischemic Stroke
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Aneurysm
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Arteriovenous Malformation and Fistulas (AVM)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Stenosis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Acandis GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Asahi Intecc Co. Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Imperative Care Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Integer Holdings Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Johnson & Johnson
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Medtronic plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 MicroPort Scientific Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Penumbra Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Perflow Medical Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Rapid Medical
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stryker Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio